News Conference News ESC 2023 ESC Focused Update on HF Synthesizes New Trial Data for Practical Use L.A. McKeown September 01, 2023
News Daily News Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel L.A. McKeown August 23, 2023
News Conference News TCT 2022 SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss Michael O'Riordan September 19, 2022
News Conference News ACC 2021 Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO Michael O'Riordan May 16, 2021
News Daily News ‘People Are Pretty Optimistic’ as Renal Denervation’s Comeback Continues Todd Neale June 24, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2019 Caitlin E. Cox May 31, 2019
News Daily News Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis Michael O'Riordan April 02, 2019
News Conference News ACC 2019 Renal Denervation May Lower Treatment Burden, as Well as Blood Pressure: RADIANCE-HTN SOLO Michael O'Riordan April 01, 2019
News Conference News TCT 2018 Untreated Accessory Arteries Dampen Renal Denervation Response: RADIANCE-HTN SOLO Todd Neale September 21, 2018
News Daily News RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline September 22, 2015
News Daily News Year in Review: Physicians Highlight the Most Important Interventional News of 2014 Todd Neale January 12, 2015
News Daily News Un Estudio Sugiere que la Denervación Renal No es Más Eficaz que un Tratamiento Farmacológico Intensificado Todd Neale December 10, 2014
News Daily News Study Suggests Renal Denervation No More Effective Than Intensified Drug Treatment Todd Neale December 10, 2014
News Daily News Role of Anticoagulation Explored in Patients With A-Fib, Renal Disease Yael L. Maxwell December 10, 2014
News Conference News ESC 2014 SYMPLICITY HTN-3: Renal Denervation Still Safe, Not Effective at 1 Year Todd Neale September 01, 2014
News Features Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3 June 24, 2014
News Conference News EuroPCR 2014 SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings Yael L. Maxwell May 22, 2014
News Conference News ACC 2014 ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation Yael L. Maxwell April 03, 2014